298.00
-5(-1.65%)
Currency In JPY
Address
1-4-1, Nishi-Honmachi
Osaka, 550-0005
Japan
Phone
81 6 4391 1110
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
214
First IPO Date
March 18, 2009
| Name | Title | Pay | Year Born |
| Takashi Shibata | President, Chief Executive Officer & Representative Director | 116.39M | 1956 |
| Keizo Nakada | Executive Officer | 0 | N/A |
| Konosuke Tanaka | Executive Officer of Personnel Affairs & Public Relations | 0 | N/A |
| Mitsuhiro Yamashita | Executive Officer of Overseas Business | 0 | N/A |
| Masaji Hashimoto | Senior Managing Director & Director | 0 | 1967 |
| Shinichi Seki | Executive Officer & GM of Infection Control Business Development Division | 0 | N/A |
| Takatoshi Osada | Senior Executive Officer of Marketing & Sales | 0 | N/A |
| Tsuyoshi Honma | Executive Officer of Accounting & IT | 0 | N/A |
Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`